Studies have shown that CSVD can promote the occurrence and development of AD by increasing the expression of Tau protein (Laing et al., 2020), and arteriolosclerosis and WMH have been shown to be associated with an increased risk of AD and dementia (Arvanitakis et al., 2016; Bos et al., 2018). This evidence concerns the gene MAPT and Alzheimer disease.